- Investing Ideas
- Belgian Pharmaceuticals & Biotech Mid-Large Cap Stocks
Belgian Pharmaceuticals & Biotech Mid-Large Cap Stocks
Results
3
0 new
Mid-Large Cap Stocks
3 companies
Financière de Tubize
Market Cap: €9.4b
Financière de Tubize SA holds a stake in UCB, a biopharmaceutical company in Belgium.
TUB
€211.40
7D
1.1%
1Y
44.0%
UCB
Market Cap: €47.6b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€250.20
7D
2.6%
1Y
35.2%
argenx
Market Cap: €48.3b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€772.00
7D
1.6%
1Y
50.1%